Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fusel alcohols and acetaldehyde in the gastrointestinal lumen refer to a group of organic compounds produced primarily through the microbial fermentation of carbohydrates or the oxidation of ethanol by gut bacteria and yeasts (Salaspuro, 2003). Acetaldehyde is a highly reactive and toxic metabolite recognized as a Group 1 carcinogen, capable of forming DNA adducts and inducing oxidative stress within the intestinal mucosa (IARC, 2012). Fusel alcohols, or higher alcohols such as isoamyl alcohol and isobutanol, are secondary products of yeast metabolism that can contribute to localized irritation and systemic effects when absorbed (Lachenmeier & Sohnius, 2008). While not traditional protein targets like receptors or enzymes, these molecules are significant pathological factors in gastrointestinal health, as their accumulation is linked to colorectal cancer, gut dysbiosis, and alcohol-related liver disease (Seitz & Stickel, 2007). Therapeutic strategies focus on the neutralization of these toxins using sequestering agents like L-cysteine or the administration of probiotics designed to enhance the enzymatic breakdown of aldehydes and alcohols within the gut lumen (Salaspuro et al., 2006).
Covalent sequestration of acetaldehyde by L-cysteine to form non-toxic 2-methyl-thiazolidine-4-carboxylic acid; enzymatic oxidation of acetaldehyde to acetate by aldehyde dehydrogenase (ALDH) expressed by probiotics; enzymatic reduction of fusel alcohols by alcohol dehydrogenase (Salaspuro et al., 2006; Tillonen et al., 1999).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fusel alcohols and acetaldehyde in the gastrointestinal lumen.